L 66 Pill - pink oval, 19mm
Pill with imprint L 66 is Pink, Oval and has been identified as Levetiracetam 750 mg. It is supplied by Accord Healthcare, Inc.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L 66
Levetiracetam
- Imprint
- L 66
- Strength
- 750 mg
- Color
- Pink
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Accord Healthcare, Inc.
- National Drug Code (NDC)
- 16729-0066 (Discontinued)
- Inactive Ingredients
-
titanium dioxide,
FD&C Yellow No. 6,
ferric oxide red,
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
polyethylene glycol 3350,
povidone k30,
polyvinyl alcohol,
magnesium silicate
Note: Inactive ingredients may vary.
Related images for "L 66"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (429)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam (Intravenous) (Advanced Reading)
- Levetiracetam (Oral) (Advanced Reading)
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
